Welcome to performance-materials.net, the one-stop source of information about the advanced materials industry worldwide. Coverage includes features, news and events information about engineering plastics, composites and ceramics. Membership gives full access to daily updates plus over five years of industry archives.


Orthopaedics company ReGen Biologics Inc said it completed a US$2.5 million private placement of convertible notes and at the same time, submitted a new 510(k) application seeking clearance from the US Food and Drug Administration (FDA) of its collagen scaffold for reinforcement and repair of meniscus tissue.